134 related articles for article (PubMed ID: 17227819)
1. Influence of acute normovolaemic haemodilution on the dose-response relationship and time course of action of cisatracurium besylate.
Dahaba AA; Wang G; Xu X; Liu X; Wu X; Bornemann H; Metzler H
Br J Anaesth; 2007 Mar; 98(3):342-6. PubMed ID: 17227819
[TBL] [Abstract][Full Text] [Related]
2. Influence of acute normovolaemic haemodilution on the dose-response relationship, time-course of action and pharmacokinetics of rocuronium bromide.
Dahaba AA; Perelman SI; Moskowitz DM; Bennett HL; Shander A; Oettl K; Reibnegger G; Metzler H
Br J Anaesth; 2006 Oct; 97(4):482-8. PubMed ID: 16873389
[TBL] [Abstract][Full Text] [Related]
3. No regional difference in cisatracurium dose-response and time-course-of-action between patients in China and Bosnia.
Dahaba AA; Suljevic I; Bornemann H; Wu XM; Metzler H
Br J Anaesth; 2011 Mar; 106(3):331-5. PubMed ID: 21205623
[TBL] [Abstract][Full Text] [Related]
4. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
7. Influence of acute normovolemic hemodilution on the pharmacokinetics of Cisatracurium Besylate.
Dahaba AA; Suljevic I; Oettl K; Xiao Z; Dong H; Xiong L; Reibnegger G
Minerva Anestesiol; 2013 Nov; 79(11):1238-47. PubMed ID: 23698546
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of cisatracurium in patients undergoing surgery with two hemodilution methods.
Guo J; Yuan X; Zhou X; Jin X
J Clin Anesth; 2017 May; 38():75-80. PubMed ID: 28372687
[TBL] [Abstract][Full Text] [Related]
9. Influence of acute normovolaemic haemodilution on the dose-response and time-course of action of atracurium.
Xue FS; Liao X; Liu JH; Zhang YM; An G; Luo LK
Acta Anaesthesiol Scand; 2000 Feb; 44(2):163-9. PubMed ID: 10695909
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
12. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
Arain SR; Kern S; Ficke DJ; Ebert TJ
Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracurium.
Chen C; Yamaguchi N; Varin F
Br J Anaesth; 2008 Dec; 101(6):788-97. PubMed ID: 18974056
[TBL] [Abstract][Full Text] [Related]
14. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
Barrio J; San Miguel G; García V; Pelegrín F
Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of atracurium, cisatracurium and vecuronium during anaesthesia for laparoscopic surgery].
Paśko-Majewska M; Owczuk R; Wujtewicz M
Anestezjol Intens Ter; 2011; 43(1):9-13. PubMed ID: 21786523
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: A prospective cohort study.
Zanjani AP; Maghsoudloo M; Makarem J; Farokhnia F; Fazli M; Khan ZH
J Clin Anesth; 2017 Feb; 36():84-87. PubMed ID: 28183581
[TBL] [Abstract][Full Text] [Related]
18. [Priming technique with cisatracurium Onset time at the laryngeal muscles].
Schmidt J; Albrecht S; Petterich N; Fechner J; Klein P; Irouschek A
Anaesthesist; 2007 Oct; 56(10):992-1000. PubMed ID: 17598079
[TBL] [Abstract][Full Text] [Related]
19. Determining the potency of neuromuscular blockers: are traditional methods flawed?
Kopman AF; Lien CA; Naguib M
Br J Anaesth; 2010 Jun; 104(6):705-10. PubMed ID: 20430764
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a new piezoelectric train-of-four neuromuscular monitor, the ParaGraph, and the Relaxometer mechanomyograph.
Dahaba AA; Von Klobucar F; Rehak PH; List WF
Br J Anaesth; 1999 May; 82(5):780-2. PubMed ID: 10536564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
